Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • pharma news

    Tag: pharma news

    You Searched For "pharma news"
    Mylan to infuse USD 1 billion on capex in India

    Mylan to infuse USD 1 billion on capex in India

    Medical Dialogues Bureau30 Sept 2019 4:00 AM
    Mylan Global President and Executive Director Rajiv Malik said the company had been investing close to about USD 400 million or USD 450 million...
    CDSCO warns against Cancer Causing Impurities in anti-acidity drug Ranitidine, writes to state drug controllers

    CDSCO warns against Cancer Causing Impurities in anti-acidity drug Ranitidine, writes to state drug controllers

    Farhat Nasim25 Sept 2019 7:49 AM
    New Delhi: To ensure patient safety, the country's apex drug regulatory body, Central Drugs Standard Control Organisation (CDSCO) has ordered an...
    Laurus Labs to acquire subsidiary of ASPEN Pharmacare

    Laurus Labs to acquire subsidiary of ASPEN Pharmacare

    Farhat Nasim24 Sept 2019 4:00 AM
    "The completion of conditions precedent, by way of cash consideration of ZAR 75,000, the Pharmaceutical company said in a statement here. The...
    CCI approves sale, restructuring of Apollo Pharmacy

    CCI approves sale, restructuring of Apollo Pharmacy

    Medical Dialogues Bureau24 Sept 2019 3:45 AM
    NEW DELHI: The Competition Commission on Monday said it has approved the restructuring of Apollo Hospitals Enterprise Ltd's pharmacy business and its...
    Make drugmakers upload data in SUGAM portal: CDSCO Committee recommends State Drug Authorities

    Make drugmakers upload data in SUGAM portal: CDSCO Committee recommends State Drug Authorities

    Farhat Nasim23 Sept 2019 12:16 PM
    New Delhi: The Drugs Consultative Committee (DCC), functional under Central Drugs Standard Control Organisation (CDSCO), recently recommended the...
    Novo Nordisk wins USFDA nod for oral diabetes drug Rybelsus

    Novo Nordisk wins USFDA nod for oral diabetes drug Rybelsus

    Medical Dialogues Bureau23 Sept 2019 8:46 AM
    Novo Nordisk did not disclose what it plans to charge for the new oral treatment, called Rybelsus, but said it would be "competitively priced" with...
    Biocon gets USFDA Form 483 with 8 observations for 2 new facilities in Bengaluru

    Biocon gets USFDA Form 483 with 8 observations for 2 new facilities in Bengaluru

    Medical Dialogues Bureau23 Sept 2019 4:45 AM
    "At the conclusion of the inspection, we received a Form 483 with four observations for the new Drug Substance facility, three observations for the...
    Dr Reddys suspends worldwide supply of Ranitidine over cancer fears until USFDA probe over

    Dr Reddys suspends worldwide supply of Ranitidine over cancer fears until USFDA probe over

    Medical Dialogues Bureau23 Sept 2019 4:30 AM
    Ranitidine is an Over-The-Counter (OTC) and prescription drug which decreases the amount of acid created by the stomach.Hyderabad: Dr Reddy's...
    CDSCO directs makers of Aceclofenac, Drotaverine Hydrochloride FDC to conduct Active Post Marketing Surveillance on atleast 200 patients

    CDSCO directs makers of Aceclofenac, Drotaverine Hydrochloride FDC to conduct Active Post Marketing Surveillance on atleast 200 patients

    Medical Dialogues Bureau22 Sept 2019 6:00 AM
    New Delhi: Through a recent notification, the Central Drugs Standard Control Organisation(CDSCO) has directed all the manufacturers of Fixed-Dose...
    Regulation of OTC drugs : CDSCO to soon amend Schedule K of Drugs and Cosmetics Act

    Regulation of OTC drugs : CDSCO to soon amend Schedule K of Drugs and Cosmetics Act

    Farhat Nasim21 Sept 2019 9:51 AM
    The Sub-Committee is of the opinion that there is an urgent need for defining the Over-the-Counter (OTC) drugs and to lay down specific provisions for...
    Strides Pharma re-enters injectable biz by infusing Rs 280 crore for controlling stake in Stelis Biopharma

    Strides Pharma re-enters injectable biz by infusing Rs 280 crore for controlling stake in Stelis Biopharma

    Farhat Nasim21 Sept 2019 6:34 AM
    Bengaluru-based Strides has already invested USD 35 million (about Rs 245 crore) for a 43 per cent ownership in Stelis.New Delhi: Strides Pharma...
    Novo Nordisk Tresiba shows lower risk of hypo in adults with Type 2 Diabetes

    Novo Nordisk Tresiba shows lower risk of hypo in adults with Type 2 Diabetes

    Medical Dialogues Bureau21 Sept 2019 4:00 AM
    "We are delighted that the findings of the CONCLUDE trial support what we have seen previously across the Tresiba clinical development programme,"...
    PrevNext

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok